Genes, Neurofibromatosis 1
"Genes, Neurofibromatosis 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumor suppressor genes located on the long arm of human chromosome 17 in the region 17q11.2. Mutation of these genes is thought to cause NEUROFIBROMATOSIS 1, Watson syndrome, and LEOPARD syndrome.
MeSH Number(s)
G05.360.340.024.340.375.249.340
G05.360.340.024.340.415.400.340
Concept/Terms
Genes, Neurofibromatosis 1- Genes, Neurofibromatosis 1
- Genes, nf 1
- Gene, nf 1
- nf 1 Gene
- nf 1 Genes
- nf1 Genes
- Neurofibromatosis 1 Genes
- Neurofibromatosis 1 Gene
- Genes, nf1
- Gene, nf1
- nf1 Gene
Below are MeSH descriptors whose meaning is more general than "Genes, Neurofibromatosis 1".
Below are MeSH descriptors whose meaning is more specific than "Genes, Neurofibromatosis 1".
This graph shows the total number of publications written about "Genes, Neurofibromatosis 1" by people in Harvard Catalyst Profiles by year, and whether "Genes, Neurofibromatosis 1" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 2 | 1 | 3 |
| 1994 | 2 | 0 | 2 |
| 1995 | 1 | 0 | 1 |
| 1996 | 3 | 0 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 2 | 4 |
| 2002 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 3 |
| 2011 | 2 | 2 | 4 |
| 2012 | 3 | 0 | 3 |
| 2013 | 0 | 5 | 5 |
| 2014 | 0 | 3 | 3 |
| 2016 | 0 | 2 | 2 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
Below are the most recent publications written about "Genes, Neurofibromatosis 1" by people in Profiles.
-
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. Nat Med. 2021 01; 27(1):165-173.
-
Emerging therapeutic targets for neurofibromatosis type 1. Expert Opin Ther Targets. 2018 05; 22(5):419-437.
-
Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1. J Neurosci Res. 2019 01; 97(1):45-56.
-
A Braf kinase-inactive mutant induces lung adenocarcinoma. Nature. 2017 08 10; 548(7666):239-243.
-
The Wild-Type NF1 Gene: It's a Real Turnoff. J Pediatr Ophthalmol Strabismus. 2017 Jul 01; 54(4):204-205.
-
Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1. PLoS One. 2017; 12(1):e0170348.
-
NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma. Adv Anat Pathol. 2017 Jan; 24(1):1-14.
-
Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations. Oncotarget. 2016 May 17; 7(20):29211-5.
-
Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers. J Clin Invest. 2016 06 01; 126(6):2181-90.
-
Whole-genome characterization of chemoresistant ovarian cancer. Nature. 2015 May 28; 521(7553):489-94.